United Kingdom · Question · Written question
UIN 75426
Medical Treatments
Introduced
16 July 2020
Last action
20 August 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 August 2020
Summary
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the availability of (a) radioligand therapy and (b) short shelf-life medicines after the end of the transition period.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 July 2020
Written question
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the availability of (a) radioligand therapy and (b) short shelf-life medicines after the end of the transition period.
Source: Commons
20 August 2020
Answer
The United Kingdom’s published approach sets out how we want to facilitate trade in medicinal products, including radioligand therapy and short shelf-life medicines, to support high levels of patient safety.We will continue to work closely with the pharma...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-07-16/75426
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1225699
- uk · wq-1225699 · source updated 20 August 2020